Chapter 11: The Challenge of Global Bioethics
Case Presentation: “The Devil’s Experiment”—STD Research in Guatemala draws upon
“Ethically Impossible”: STD Research in Guatemala from 1946 to 1948 (Washington, D.C.: Presidential
Commission for the Study of Bioethical Issues, 2011); Matthew Walter, “Human Experiments: First, Do
Harm,” Nature 482, no. 7384 (2012): 148–152; Spencer McFarlane, “President’s Bioethics Commission
Continues Review of Guatemalan Syphilis Experiments,” Biopolitical Times, May 26, 2011; Rory Carroll,
“Guatemala Victims of US Syphilis Study Still Haunted by the ‘Devil’s Experiment,’ ” The Guardian, June 8,
2011; Kara Rogers, “Guatemala Syphilis Experiment,” Encyclopaedia Britannica; Susan M. Reverby, “After
Information for the Social Context: Clinical Trials in the Developing World draws on New York
Times articles by Sheryl Gay Stolberg, “U.S. AIDS Research Abroad Sets Off Outcry Over Ethics,”
September 18, 1997; and “Placebo Use Is Suspended In Overseas AIDS Trials,” February 19, 1998; by
Howard W. French, “AIDS Research in Africa: Juggling Risks and Hopes,” October 9, 1997; by Tamar
Lewin, “Families Sue Pfizer on Test Of Antibiotic,” August 30, 2001; and by Donald G. McNeil, Jr.,
“Nigerians Receive First Payments for Children Who Died in 1996 Meningitis Drug Trial,” August 11, 2011.
For the Trovan trial, also see the following Washington Post articles: by Joe Stephens, “Panel Faults Pfizer
Updates to Social Context: Pandemic—AIDS Worldwide draw on the following sources:
“Statistics Worldwide,” amfAR, July 2015; “Africa’s Orphaned
and Vulnerable Generations: Children Affected by AIDS,” UNICEF, August 2006; “Children Orphaned by
HIV and AIDS,” Avert, March 27, 2014; Dick Durevall and